Výsledky vyhledávání - "Ana Arancón Pardo"

Real-World Study of HIV Patients Starting Antiretroviral Treatment With Boosted Protease Inhibitors in the Integrase Inhibitors Era

Autor: Ana Arancón Pardo, Carmen Mateos Salillas, Inmaculada Jiménez-Nácher, Juan González García, Alicia Herrero Ambrosio

Background Boosted-protease inhibitors (b-PIs) are not recommended for initial therapy in HIV patients, but there is still a cohort of patients who could benefit from this antiretroviral treatment (ART). The purpose of this study was to analyze the p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0da46964839cd76ed7d031c88679e80e
https://doi.org/10.21203/rs.3.rs-1836324/v1

Zobrazit plný text záznamu

Real-World Experience with Two-Drug Regimens in HIV-1-Infected Patients Beyond the Indication of Clinical Trials: 48 Weeks' Results

Autor: María Ángeles González Fernández, Ana Arancón Pardo, Francisco Moreno, Marta Moreno Palomino, Juan González-García, Inmaculada Jiménez-Nácher, Alicia Herrero Ambrosio

Publikováno v: AIDS research and human retroviruses. 37(10)

Data on two-drug regimens (2DRs) have shown high efficacy and tolerability in treatment-naive and treatment-experienced HIV-1 patients. Current guidelines recommend 2DRs as alternative to three-drug regimens (3DRs) to reduce long-term drug exposure a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a90a48ebb3e0df0074fd0be81fc7c06
https://pubmed.ncbi.nlm.nih.gov/34465135

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání